Lactate preserves neuronal metabolism and function following antecedent recurrent hypoglycemia

Journal of Clinical Investigation

Volumn 123, Issue 5, 2013, Pages 1988-1998

  Herzog, Raimund I ^a   Jiang, Lihong ^a   Herman, Peter ^a   Zhao, Chen ^a   Sanganahalli, Basavaraju G ^a   Mason, Graeme F ^a   Hyder, Fahmeed ^a   Rothman, Douglas L ^a   Sherwin, Robert S ^a   Behar, Kevin L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLUCOSE; GLUTAMIC ACID; GLYCINE; LACTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN LEVEL; BRAIN METABOLISM; CONTROLLED STUDY; DISEASE MODEL; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HYPOGLYCEMIA; MALE; MEMBRANE TRANSPORT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; TRANSPORT KINETICS;

ANIMALS; BLOOD GLUCOSE; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIA; INSULIN; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURONS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE;

EID: 84877144584     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65105     Document Type: Article

References (55)

1. [No authors listed]. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-986.
2. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2004;350(22):2272-2279.
3. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008;29(4):494-511.
4. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes. 1994; 43(11):1311-1317.
5. Maran A, et al. Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type I diabetic subjects. Diabetologia. 2000;43(6):733-741.
6. Page KA, et al. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes. 2009; 58(5):1237-1244.
7. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic Acid transport and utilization in type 1 diabetes. Diabetes. 2006;55(4):929-934.
8. 13C]-NMR. J Cereb Blood Flow Metab. 2010; 30(6):1200-1213.
9. Deelchand DK, Shestov AA, Koski DM, Ugurbil K, Henry PG. Acetate transport and utilization in the rat brain. J Neurochem. 2009;109(suppl 1):46-54.
10. Jiang L, et al. Recurrent antecedent hypoglycemia alters neuronal oxidative metabolism in vivo. Diabetes. 2009;58(6):1266-1274.
11. 13C-Labeled substrates and the cerebral metabolic compartmentalization of acetate and lactate. Brain Res. 2003;992(1):43-52.
12. 13C nuclear magnetic resonance spectroscopy. J Neurosci. 2010;30(42):13983-13991.
13. Shulman RG, Hyder F, Rothman DL. Lactate efflux and the neuroenergetic basis of brain function. NMR Biomed. 2001;14(7-8):389-396.
14. Avogaro A, et al. Substrate availability other than glucose in the brain during euglycemia and insulin-induced hypoglycemia in dogs. Metabolism. 1990; 39(1):46-50.
15. Chan O, et al. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes. 2008;57(5):1363-1370.
16. McCrimmon RJ, et al. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes. 2006;55(6):1755-1760.
17. Sherwin RS. Bringing light to the dark side of insulin: a journey across the blood-brain barrier. Diabetes. 2008;57(9):2259-2268.
18. 13)C isotopic turnover to determine rates of brain metabolism in vivo. Metab Eng. 2004;6(1):75-84.
19. Patel AB, de Graaf RA, Mason GF, Rothman DL, Shulman RG, Behar KL. The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc Natl Acad Sci U S A. 2005;102(15):5588-5593.
20. Dienel GA. Brain lactate metabolism: the discoveries and the controversies. J Cereb Blood Flow Metab. 2012;32(7):1107-1138.
21. 13C] NMR spectroscopy in vivo. A practical guide. NMR Biomed. 2011; 24(8):958-972.
22. de Graaf RA, Mason GF, Patel AB, Rothman DL, Behar KL. Regional glucose metabolism and glutamatergic neurotransmission in rat brain in vivo. Proc Natl Acad Sci U S A. 2004;101(34):12700-12705.
23. Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 2004;27(8):489-495.
24. Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab. 2006;26(7):865-877.
25. Duarte JM, Gruetter R. Characterization of cerebral glucose dynamics in vivo with a four-state conformational model of transport at the blood-brain barrier. J Neurochem. 2012;121(3):396-406.
26. Gruetter R, Ugurbil K, Seaquist ER. Steady-state cerebral glucose concentrations and transport in the human brain. J Neurochem. 1998;70(1):397-408.
27. Seaquist ER, Damberg GS, Tkac I, Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes. 2001;50(10):2203-2209.
28. de Graaf RA, et al. Differentiation of glucose transport in human brain gray and white matter. J Cereb Blood Flow Metab. 2001;21(5):483-492.
29. Blodgett DM, De Zutter JK, Levine KB, Karim P, Carruthers A. Structural basis of GLUT1 inhibition by cytoplasmic ATP. J Gen Physiol. 2007;130(2):157-168.
30. van Hall G, et al. Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab. 2009;29(6):1121-1129.
31. Nemoto EM, Hoff JT, Severinghaus JW. Lactate uptake and metabolism by brain during hyperlactatemia and hypoglycemia. Stroke. 1974;5(1):48-53.
32. Dalsgaard MK. Fuelling cerebral activity in exercising man. J Cereb Blood Flow Metab. 2006;26(6):731-750.
33. Gladden LB. Lactate metabolism: a new paradigm for the third millennium. J Physiol. 2004;558(pt 1):5-30.
34. Powell AM, Sherwin RS, Shulman GI. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits. J Clin Invest. 1993;92(6):2667-2674.
35. Rasmussen P, Wyss MT, Lundby C. Cerebral glucose and lactate consumption during cerebral activation by physical activity in humans. FASEB J. 2011;25(9):2865-2873.
36. 13)C magnetic resonance spectroscopy. Diabetes. 2011;60(5):1467-1473.
37. van de Ven KC, van der Graaf M, Tack CJ, Heerschap A, de Galan BE. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes. 2012; 61(8):1974-1977.
38. Sprengers ED, Koenderman AH, Staal GE. Mitochondrial and cytosolic hexokinase from rat brain: one and the same enzyme? Biochim Bioph ys Acta. 1983; 755(1):112-118.
39. Grossbard L, Schimke RT. Multiple hexokinases of rat tissues. Purification and comparison of soluble forms. J Biol Chem. 1966;241(15):3546- 3560.
40. Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER. Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res. 2005;79(1-2):42-47.
41. Herzog RI, Chan O, Yu S, Dziura J, McNay EC, Sherwin RS. Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology. 2008;149(4):1499-1504.
42. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab. 2007;27(11):1766-1791.
43. Itoh Y, et al. Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo. Proc Natl Acad Sci U S A. 2003;100(8):4879-4884.
44. Mangia S, Simpson IA, Vannucci SJ, Carruthers A. The in vivo neuron-to-astrocyte lactate shuttle in human brain: evidence from modeling of measured lactate levels during visual stimulation. J Neurochem. 2009;109(suppl 1):55-62.
45. 1H NMR spectra with increased magnetic field strength. J Magn Reson. 1998;135(1):260-264.
46. Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson. 2001;153(2):155-177.
47. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol. 1985;30(4):341-344.
48. 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn Reson Med. 2008;59(1):1-6.
49. 13C]-NMR spectroscopy of cerebral metabolism. NMR Biomed. 2003;16(6-7):339-357.
50. Katsura K, Folbergrova J, Siesjo BK. Changes in labile energy metabolites, redox state and intracellular pH in postischemic brain of normo- and hyperglycemic rats. Brain Res. 1996;726(1-2):57-63.
51. Ponten U, Ratcheson RA, Salford LG, Siesjo BK. Optimal freezing conditions for cerebral metabolites in rats. J Neurochem. 1973;21(5):1127-1138.
52. Patel AB, Rothman DL, Cline GW, Behar KL. Glutamine is the major precursor for GABA synthesis in rat neocortex in vivo following acute GABA-transaminase inhibition. Brain Res. 2001;919(2):207-220.
53. 13)C]glucose. Brain Res Brain Res Protoc. 2003;10(3):181-190.
54. Herman P, Sanganahalli BG, Blumenfeld H, Hyder F. Cerebral oxygen demand for short-lived and steadystate events. J Neurochem. 2009;109(Suppl 1):73-79.
55. Sanganahalli BG, Herman P, Blumenfeld H, Hyder F. Oxidative neuroenergetics in event-related paradigms. J Neurosci. 2009;29(6):1707-1718.